|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ALLOS THERAPEUTICS, 10-Q, 2000-10-27 |
Next: ABN AMRO MORTGAGE CORP SERIES 1999-7, 8-K, 2000-10-27 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 3,164,496
<SECURITIES> 56,370,346
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 60,158,018
<PP&E> 733,289
<DEPRECIATION> 421,576
<TOTAL-ASSETS> 88,352,350
<CURRENT-LIABILITIES> 1,776,855
<BONDS> 22,105
0
0
<COMMON> 156,630,658
<OTHER-SE> (70,077,268)
<TOTAL-LIABILITY-AND-EQUITY> 88,352,350
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 18,409,827
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 28,846
<INCOME-PRETAX> (18,409,827)
<INCOME-TAX> 0
<INCOME-CONTINUING> (18,409,827)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (18,409,827)
<EPS-BASIC> (1.13)
<EPS-DILUTED> (1.13)
</TABLE>
|
|